A Publication for the Practising Medical Specialist, Industry Executive

Medical Device News Magazine delivers the latest updates from the medical device and biotechnology sectors. 

Stay Ahead in Medical Technology

At Medical Device News Magazine, we take pride in delivering high-quality, in-depth news. Our content goes beyond the surface, providing a comprehensive look at the trends, innovations, and breakthroughs that are shaping the future of medical technology.

In addition, we aim to offer a unique perspective on the rapidly evolving healthcare landscape. By following our news, you gain exclusive insights into industry developments, emerging technologies, and regulatory updates that impact medical devices worldwide. At the same time, you become part of a vibrant community of professionals, innovators, and thought leaders who are dedicated to advancing healthcare through cutting-edge solutions.

Furthermore, we encourage you to explore our diverse range of content, from the latest product announcements to in-depth analyses of industry trends. If our vision aligns with your objectives, we also offer opportunities for advertising and collaboration, allowing you to reach a highly engaged audience of medical technology professionals.

Stay informed, stay connected, and join us as we navigate the future of healthcare together.

Medical Device Industry News: Latest Developments, Breakthroughs, and Future Outlook

Vitestro Unveils Aletta™

Vitestro Unveils Aletta ™ | World’s 1st Autonomous Robotic Phlebotomy Device

Aletta is the first and only Autonomous Robotic Phlebotomy Device™ (ARPD™), a unique technology descriptor that establishes a new category of medical robotics dedicated to optimizing blood collection. As the exclusive ARPD™, Aletta sets the global industry standard for automated venous blood draws—enhancing clinical precision, safety, efficiency, and patient experience.

Remote Monitoring Devices

Patients Transmit More Than 15 Million Vitals Using Pylo Remote Monitoring Devices

Patients use Pylo remote monitoring devices to collect and securely transmit health data like blood pressure, weight, blood glucose, oxygen saturation, and pulse rate readings to their care teams. With this data, providers can identify potential health issues early and intervene promptly, preventing potential hospitalizations.

PathMaker Neurosystems Announces Issuance of 3 Patents

“We are pleased to see these latest patent issuances that protect PathMaker’s novel technology for the non-invasive treatment of ALS,” said Jake Maslow, J.D., Co-Founder and Chief Intellectual Property Officer at PathMaker. “These patents provide additional protection specific to the treatment of ALS that goes beyond the more than 40 issued patents we already have protecting our platform globally.”

Clinical Trials

Editas Medicine Reports New Safety and Efficacy Data from the RUBY Trial of Reni-cel in 18 Patients with Sickle Cell Disease | Presented at the European Hematology Association (EHA) Annual Congress

“These data confirm the observations from our prior clinical readouts and further support our belief that reni-cel has the potential to be a best-in-class and clinically differentiated, one-time, durable medicine that can provide life-changing clinical benefits to patients,” said Baisong Mei, M.D., Ph.D., Chief Medical Officer, Editas Medicine.

Innovent Biologics Delivers Oral Presentation on Clinical Data of IBI363 (First-in-class PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in Advanced Non-small Cell Lung Cancer and Other Solid Tumors at the 2024 ESMO Virtual Plenary

Dr. Hui Zhou, Senior Vice President of Innovent, stated: “IBI363, as a first-in-class molecule, represents Innovent’s continuous innovation and advancement in the immunotherapy field. Starting from molecular design, the unique approach of α bias with β and γ attenuated were creatively adopted, which greatly improved the therapeutic window of IL-2. Meanwhile, through the specific traction of PD-1, tumor-specific T cells expressing both PD-1 and CD25 can be selectively stimulated and amplified, thus exerting anti-tumor effects. IBI363 has demonstrated excellent druggability with antibody-like pharmacokinetics (IgG-like PK) and low immunogenicity.

Biotechnology News

VVector Bio

International Consortium to Revolutionize Viral Vector Manufacturing | Reports VVector Bio

“This project represents a paradigm shift towards improving viral vector manufacturing yields,” remarked Alina Venereo Sanchez, CEO of VVector Bio. “By integrating genomics, epigenomics, transcriptomics, metabolomics and new ways of directly integrating analytics into production, we’re poised to unlock unprecedented production capabilities.”

Our Experts – Byline Articles

Read Their Views & Share With a Colleague or Two!

Limb Loss and Preservation Registry

Limb Loss and Preservation Registry (LLPR) Transforms Care Through Data and Insights | By Shawn Murphy, Vice President, Thought Leadership & Innovation Foundation (TLI)

Shawn Murphy writes, “The Limb Loss and Preservation Registry (LLPR) represents a pivotal development in patient care. It stands as the first collaborative database that unites hospital and health systems, provider organizations such as Accountable Care Organizations (ACOs), Integrated Delivery Networks (IDNs) and orthotic/prosthetic (O&P) practices, focusing on both upper and lower extremity acquired and congenital limb differences, as well as limb preservation populations. This collective effort has the potential to drive substantial advancements in patient outcomes, treatment effectiveness and care quality.” Read to learn more.

Andrew Cleeland, CEO, Fogarty Innovation

It Takes an Ecosystem – Bringing Stakeholders Together is a Critical 1st Step to Solving Problems In Healthcare | By Andrew Cleeland, CEO, Fogarty Innovation

Andrew Cleeland writes, “Introducing a new medical therapy or technology is a complex, expensive, and time-consuming journey, one that is fraught with significant risk. While innovation often starts with a clear, well-defined unmet clinical need, it must be paired with an equally compelling value proposition. My mentor, Dr. Thomas Fogarty, once said, “An idea, by itself, has no importance whatsoever; it is the implementation of that idea and its acceptance by others that brings benefit to our patients.” Read on.

Executives on the Move

FDA Medical Device Updates

Comprehensive Insights into Medical Device & Biotechnology Company Mergers, Acquisitions & Funding

Palatin Technologies Announces $5 Million Registered Direct Offering

Palatin Technologies is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor systems, with targeted, receptor-specific product candidates for the treatment of diseases with significant unmet medical need and commercial potential. Palatin’s strategy is to develop products and then form marketing collaborations with industry leaders to maximize their commercial potential.

Laverock Therapeutics

Laverock Therapeutics Raises £13.5M

Laverock Therapeutics notes the funding will enable further development of the GEiGS technology and progression of Laverock’s programs in regenerative medicine and immuno-oncology, with a focus on Type I Diabetes and solid tumor responsive T-cell and macrophage-based immune therapies, through to in vitro and in vivo validation.

Market Reports

Advancements In Imaging

Mediso

Mediso Launches Next Generation MRI Spectrometer spinScan®

Mediso notes the spinScan® spectrometer is based on a technology that has been continuously developed for 10+ years, featuring an FPGA SoC platform with highly scalable transceiver architecture enabling more than 128 receiver channels and microsecond gradient resolution with closed-loop control via high-speed optical interfaces

Hospitals In the News

Medical Device and Biotechnology Executives: Innovative Professionals on the Move and Making Waves in the Industry

Non-Profit News

Healthcare: Understanding the Business Side of the Industry and Its Implications

Healthcare Careers

Nurses Corner

Parker Health Group Wins 2022 McKnight’s Tech Awards in Skilled Nursing

Parker Health Group was chosen as the Gold winner for achieving overall hand-hygiene compliance at or above 95%, staff time savings and efficiency versus direct observation, and positive feedback from care partners and family members for commitment to safety and quality for the last 17 months. These outcomes also improved resident, family, and care partner satisfaction and experience.

4 Most-In Demand Nursing Jobs

4 Most-In Demand Nursing Jobs

In the last decade, demand for qualified nurses has been increasing, and the pressure of a global pandemic on healthcare systems has exacerbated the nursing

Health: A Comprehensive Exploration of Wellness, Nutrition, and Overall Well-Being for a Healthier Life

Articles Designed to Inspire and Guide You Toward Achieving Excellence and Success in All Your Endeavors.